I don't think their premise is flawed. Icagen didn't do a great job in negotiating a best price for shareholders. Market cap less cash less near term milestones offsets, Pfizer is grabbing this nearly for free. But you're probably correct, they may not have any luck in squeezing Pfizer.
News 
Market Data 
Discover 
AI
